ConductScience.org, home

Trial · NCT00436917

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryAverage Intra-patient Change in Total Lumbar Spine (L1 to L4) Bone Mineral Density (BMD)Baseline and 1 yearChange: BMD values at twelve months post study entry minus BMD values at baseline, expressed as a percentage of the baseline value.
SecondaryAverage Intra-patient Change in Total Lumbar Spine (L1 to L4) Bone Mineral Density (BMD) at Year 2 Post Study EntryBaseline and 2 yearChange: BMD values at year 2 post study entry minus BMD values at baseline, expressed as a percentage of the baseline value.
SecondaryAverage Intra-patient Change in Total Lumbar Spine (L1 to L4) Bone Mineral Density (BMD) at Year 3 Post Study EntryBaseline and 3 yearChange: BMD values at year 3 post study entry minus BMD values at baseline, expressed as a percentage of the baseline value.
SecondaryAverage Intra-patient Change in Total Lumbar Spine (L1 to L4) Bone Mineral Density (BMD) at Year 4 Post Study EntryBaseline and 4 yearChange: BMD values at year 4 post study entry minus BMD values at baseline, expressed as a percentage of the baseline value.
SecondaryAverage Intra-patient Change in Total Lumbar Spine (L1 to L4) Bone Mineral Density (BMD) at Year 5 Post Study EntryBaseline and 5 yearChange: BMD values at year 5 post study entry minus BMD values at baseline, expressed as a percentage of the baseline value.
SecondaryAverage Intra-patient Change in Femoral Neck Bone Mineral Density (BMD) at Year 1 Post Study EntryBaseline and 1 yearChange: BMD values at year 1 post study entry minus BMD values at baseline, expressed as a percentage of the baseline value.
SecondaryAverage Intra-patient Change in Femoral Neck Bone Mineral Density (BMD) at Year 2 Post Study EntryBaseline and 2 yearChange: BMD values at year 2 post study entry minus BMD values at baseline, expressed as a percentage of the baseline value.
SecondaryAverage Intra-patient Change in Femoral Neck Bone Mineral Density (BMD) at Year 3 Post Study EntryBaseline and 3 yearChange: BMD values at year 3 post study entry minus BMD values at baseline, expressed as a percentage of the baseline value.
SecondaryAverage Intra-patient Change in Femoral Neck Bone Mineral Density (BMD) at Year 4 Post Study EntryBaseline and 4 yearChange: BMD values at year 4 post study entry minus BMD values at baseline, expressed as a percentage of the baseline value.
SecondaryAverage Intra-patient Change in Femoral Neck Bone Mineral Density (BMD) at Year 5 Post Study EntryBaseline and 5 yearChange: BMD values at year 5 post study entry minus BMD values at baseline, expressed as a percentage of the baseline value.
SecondaryMaximum-Grade Toxicity Incidence at Least Possibly Related to Study Medications5 yearsAdverse events were assessed per NCI Common Terminology Criteria for Adverse Events (CTCAE) Version 3.0. Grade 1=Mild, Grade 2=Moderate.
SecondaryTime to Disease ProgressionUp to 5 yearsTime to disease progression was defined as the time from date of randomization to the documentation of disease progression.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00436917/registered